Profile | GDS4284 / 1556925_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 238.861 | 53 |
GSM687648 | Patient 402 control | 212.733 | 50 |
GSM687653 | Patient 403 control | 244.96 | 53 |
GSM687658 | Patient 404 control | 402.343 | 60 |
GSM687663 | Patient 411 control | 444.502 | 61 |
GSM687668 | Patient 422 control | 439.965 | 62 |
GSM687673 | Patient 424 control | 368.479 | 58 |
GSM687678 | Patient 425 control | 659.565 | 67 |
GSM687683 | Patient 427 control | 667.535 | 67 |
GSM687688 | Patient 428 control | 234.185 | 51 |
GSM687695 | Patient 441 control | 26.5846 | 8 |
GSM687699 | Patient 443 control | 224.891 | 47 |
GSM687704 | Patient 444 control | 726.905 | 69 |
GSM687707 | Patient 448 control | 624.681 | 67 |
GSM687712 | Patient 449 control | 397.097 | 60 |
GSM687719 | Patient 450 control | 360.066 | 56 |
GSM687724 | Patient 451 control | 482.126 | 63 |
GSM687728 | Patient 452 control | 203.451 | 47 |
GSM687646 | Patient 401 treated 24h | 566.482 | 65 |
GSM687649 | Patient 402 treated 24h | 284.583 | 55 |
GSM687665 | Patient 411 treated 24h | 290.006 | 53 |
GSM687651 | Patient 402 treated 4 weeks | 301.551 | 55 |
GSM687667 | Patient 411 treated 4 weeks | 401.809 | 60 |
GSM687670 | Patient 422 treated 24h | 304.394 | 55 |
GSM687671 | Patient 422 treated 4 weeks | 510.328 | 64 |
GSM687654 | Patient 403 treated 24h | 309.878 | 57 |
GSM687675 | Patient 424 treated 24h | 369.742 | 58 |
GSM687685 | Patient 427 treated 24h | 211.556 | 49 |
GSM687656 | Patient 403 treated 4 weeks | 258.871 | 55 |
GSM687677 | Patient 424 treated 4 weeks | 488.954 | 63 |
GSM687687 | Patient 427 treated 4 weeks | 522.892 | 64 |
GSM687692 | Patient 428 treated 4h | 296.246 | 55 |
GSM687716 | Patient 449 treated 4h | 424.898 | 62 |
GSM687722 | Patient 450 treated 4h | 324.339 | 55 |
GSM687680 | Patient 425 treated 24h | 338.115 | 57 |
GSM687690 | Patient 428 treated 24h | 142.996 | 42 |
GSM687700 | Patient 443 treated 24h | 379.222 | 55 |
GSM687705 | Patient 444 treated 24h | 656.188 | 68 |
GSM687714 | Patient 449 treated 24h | 294.21 | 56 |
GSM687721 | Patient 450 treated 24h | 242.394 | 48 |
GSM687682 | Patient 425 treated 4 weeks | 300.323 | 56 |
GSM687694 | Patient 428 treated 4 weeks | 365.483 | 59 |
GSM687702 | Patient 443 treated 4 weeks | 314.257 | 55 |
GSM687718 | Patient 449 treated 4 weeks | 492.789 | 64 |
GSM687723 | Patient 450 treated 4 weeks | 362.428 | 58 |
GSM687661 | Patient 404 treated 4h | 451.941 | 62 |
GSM687710 | Patient 448 treated 4h | 497.59 | 64 |
GSM687726 | Patient 451 treated 4h | 670.244 | 68 |
GSM687730 | Patient 452 treated 4h | 262.734 | 38 |
GSM687660 | Patient 404 treated 24h | 99.7811 | 29 |
GSM687697 | Patient 441 treated 24h | 318.679 | 53 |
GSM687709 | Patient 448 treated 24h | 746.346 | 70 |
GSM687725 | Patient 451 treated 24h | 494.472 | 63 |
GSM687729 | Patient 452 treated 24h | 147.85 | 35 |
GSM687727 | Patient 451 treated 4 weeks | 844.223 | 71 |
GSM687731 | Patient 452 treated 4 weeks | 361.658 | 57 |